{"id":"n_svztnownvuyybqfoacia","seq":12644641,"kind":"article","title":"Nelkarmi Wins Accelerated FDA Approval for ALK-Positive Lung Cancer That Progressed After Alectinib or Two Earlier Drugs","url":"https://www.medicaldaily.com/nelkarmi-neladalkib-fda-accelerated-approval-alk-lung-cancer-481392","summary":"The FDA granted accelerated approval to Nelkarmi for advanced ALK-positive non-small cell lung cancer after prior targeted therapies, based on tumor response data from the ALKOVE-1 trial.","published":"2026-11-18T21:33:31Z","seen":"2026-11-18T21:45:21Z","lang":"en","country":"US","source":{"id":"kite-medicaldaily-com-05fda3","name":"medicaldaily.com","domain":"medicaldaily.com"},"via":"kite-medicaldaily-com-05fda3","topics":["medicine"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q21099132","name":"alectinib","type":"other"}],"mentions":2,"story":"st_7enmdarzhqdoxs42lc6a","category":"health","category_p":0.58,"sentiment":"positive","tone":0.42,"political":0.12}